U.K.'s MHRA to seek new CEO as Hudson steps down next fall

Ian Hudson said he will step down in September 2019 as CEO of the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) for "personal and professional" reasons. Hudson has been CEO since September 2013.

MHRA, which faces a potential restructuring of medicines regulation catalyzed by Brexit, will begin its search for a new CEO early next year (see "Brexit Deal Smooths Transition for MAAs, IP Protections")...